Allergy Therapeutics AGYTF Stock
Allergy Therapeutics Price Chart
Allergy Therapeutics AGYTF Financial and Trading Overview
| Allergy Therapeutics stock price | 0.09 USD |
| Previous Close | 0.18 USD |
| Open | 0.05 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.18 - 0.18 USD |
| 52 Week Range | 0.05 - 0.28 USD |
| Volume | 300 USD |
| Avg. Volume | 7 USD |
| Market Cap | 118.84M USD |
| Beta (5Y Monthly) | 0.950191 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AGYTF Valuation Measures
| Enterprise Value | 102.73M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.6331818 |
| Price/Book (mrq) | 2.9166667 |
| Enterprise Value/Revenue | 1.412 |
| Enterprise Value/EBITDA | -12.518 |
Trading Information
Allergy Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.950191 |
| 52-Week Change | -38.16% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.28 USD |
| 52 Week Low | 0.05 USD |
| 50-Day Moving Average | 0.18 USD |
| 200-Day Moving Average | 0.18 USD |
AGYTF Share Statistics
| Avg. Volume (3 month) | 7 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 679.11M |
| Float | 95.45M |
| Short Ratio | N/A |
| % Held by Insiders | 123.30% |
| % Held by Institutions | 6.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -18.93% |
| Operating Margin (ttm) | -17.0030% |
| Gross Margin | 68.03% |
| EBITDA Margin | -11.27% |
Management Effectiveness
| Return on Assets (ttm) | -9.56% |
| Return on Equity (ttm) | -31.69% |
Income Statement
| Revenue (ttm) | 72.77M USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | -20.59% |
| Gross Profit (ttm) | 49.51M USD |
| EBITDA | -8207000 USD |
| Net Income Avi to Common (ttm) | -13776000 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.52M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 10.53M USD |
| Total Debt/Equity (mrq) | 27.42 USD |
| Current Ratio (mrq) | 2.381 |
| Book Value Per Share (mrq) | 0.06 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14372000 USD |
| Levered Free Cash Flow (ttm) | -11695250 USD |
Profile of Allergy Therapeutics
| Country | United States |
| State | N/A |
| City | Worthing |
| Address | Dominion Way |
| ZIP | BN14 8SA |
| Phone | 44 1903 844 700 |
| Website | https://www.allergytherapeutics.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 600 |
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Acarovac Plus, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Q&A For Allergy Therapeutics Stock
What is a current AGYTF stock price?
Allergy Therapeutics AGYTF stock price today per share is 0.09 USD.
How to purchase Allergy Therapeutics stock?
You can buy AGYTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Allergy Therapeutics?
The stock symbol or ticker of Allergy Therapeutics is AGYTF.
Which industry does the Allergy Therapeutics company belong to?
The Allergy Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does Allergy Therapeutics have in circulation?
The max supply of Allergy Therapeutics shares is 4.86B.
What is Allergy Therapeutics Price to Earnings Ratio (PE Ratio)?
Allergy Therapeutics PE Ratio is now.
What was Allergy Therapeutics earnings per share over the trailing 12 months (TTM)?
Allergy Therapeutics EPS is -0.01 USD over the trailing 12 months.
Which sector does the Allergy Therapeutics company belong to?
The Allergy Therapeutics sector is Healthcare.